PSNL · Personalis, Inc. · Metrics
$15.94
+0.06 (+0.38%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.70B
Shares
106.80M
Volume · Oct 20
2.12M
Avg daily vol (3M)
2.97M
PSNL metrics
87 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$15.94
Market cap
$1.70B
Price action
20 metricsPrice change (1W)
+0.5%
Price change (30D)
-2.2%
Price change (3M)
+19.0%
Price change (6M)
+150.5%
Price change (YTD)
+99.5%
Price change (1Y)
+73.9%
Trailing year
Price change (5Y)
-20.0%
52-week high
$18.38
52-week low
$5.04
Change from 52-week high
-13.6%
Change from 52-week low
+215.1%
Annualized volatility
85.7%
Annualized volatility (3M)
51.5%
Beta
2.9
RSI (14D)
46.7
Price vs SMA 50
-1.4%
Price vs SMA 200
+44.9%
Avg volume (3M)
3.12M
Relative volume
1.0
Average dollar volume
$47.89M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
106.80M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
24.0×
reciprocal yield 4.2%
P / book
7.1
reciprocal yield 14.1%
FCF yield
-6.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
8.0×
reciprocal yield 12.5%
EV / revenue historical average (5Y)
8.0×
reciprocal yield 12.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
22.7%
Operating margin
-164.1%
Trailing 12 months
Net margin
-153.8%
Gross profit (TTM)
$22.08M
Operating profit (TTM)
−$114.31M
Net income (TTM)
−$107.18M
Trailing 12 months
Diluted EPS (TTM)
$-1.09
FCF margin
-144.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+30.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$69.67M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.1%
Year over year · more shares
Revenue CAGR (3Y)
+2.3%
Revenue CAGR (5Y)
-2.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-45.6%
Return on assets
-34.3%
Debt / equity
—
Current ratio
5.3
EBITDA (TTM)
−$104.60M
Free cash flow (TTM)
−$100.97M
Quick ratio
5.3
Interest coverage
-536.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$93.97M
Total assets
$312.13M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$92.30M
Capital expenditures (TTM)
$8.68M
R&D (TTM)
$56.12M
SG&A (TTM)
$67.03M
Stock compensation (TTM)
$10.91M
R&D / revenue
80.5%
Stock compensation / revenue
15.7%
Ownership (13F)
9 metrics13F filers
158
13F filer change QoQ
+16
Institutional ownership
80.6%
Conviction holders (share of 13F filers)
1.9%
Crowding (high-turnover and private-fund holders)
29.3%
Private-fund adviser ownership
25.6%
Active holders' share change QoQ
-7.2%
Holder tenure
10.9
Price vs estimated holder cost
+79.8%
Ownership (registered funds)
1 metricsIndex-fund ownership
8.5%
Short interest
3 metricsShort interest
7.9%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
77 / 100
Insider activity
2 metricsNet insider buying (90D)
−$266,916
Insider-sentiment score
31 / 100
Risk flags
1 metricsGoing concern
—